News & Perspective

Dec 20, 2006

Dec 20, 2006

HHS cancels VaxGen anthrax vaccine contract

(CIDRAP News) – The US government yesterday canceled its $877.5 million contract with VaxGen Inc. for a new anthrax vaccine, after problems with the vaccine's stability caused the company to miss a deadline for starting a clinical trial.